[Federal Register Volume 87, Number 66 (Wednesday, April 6, 2022)]
[Notices]
[Pages 19938-19939]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-07247]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2022-0046]


Advisory Committee to the Director (ACD), Centers for Disease 
Control and Prevention (CDC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Advisory Committee to the 
Director, Centers for Disease Control and Prevention (ACD, CDC). This 
meeting is open to the public. Time will be available for public 
comment. The meeting will be webcast live via the World Wide Web.

DATES: The meeting will be held on May 3, 2022, from 11:00 a.m. to 4:00 
p.m., EDT (times subject to change). The public may submit written 
comments from April 6, 2022 through April 28, 2022.

ADDRESSES: You may submit comments identified by Docket No. CDC-2022-
0046 by any of the following methods:
    <bullet> Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
    <bullet> Mail: Kerry Caudwell, MPA, Centers for Disease Control and 
Prevention, 1600 Clifton Road NE, MS H21-10, Atlanta, Georgia 30329-
4027. Attn: Docket No. CDC-2022-0046.
    Instructions: All submissions received must include the Agency name 
and Docket Number. All relevant comments received in conformance with 
the https://www.regulations.gov suitability policy will be posted 
without change to https://www.regulations.gov, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to https://www.regulations.gov.
    Written public comments submitted up to 72 hours prior to the ACD 
meeting will be provided to ACD members before the meeting.
    Written comments received in advance of the meeting will be 
included in the official record of the meeting.

FOR FURTHER INFORMATION CONTACT: Kerry Caudwell, MPA, Centers for 
Disease Control and Prevention, Office of the Chief of Staff, 1600 
Clifton Road NE, MS H21-10, Atlanta, Georgia 30329-4027, Telephone: 
(404) 639-7000; Email Address: <a href="/cdn-cgi/l/email-protection#88c9cbcce1faedebfce7fac8ebeceba6efe7fe"><span class="__cf_email__" data-cfemail="2e6f6d6a475c4b4d5a415c6e4d4a4d00494158">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: 
    Purpose: The Advisory Committee to the Director (ACD), CDC, shall 
advise the Secretary, HHS, and the Director, CDC, on policy and broad 
strategies that will enable CDC to fulfill its mission of protecting 
health through health promotion, prevention, and preparedness. The 
committee recommends ways to prioritize CDC's activities, improve 
results, and address health disparities. It also provides guidance to 
help CDC work more effectively with its various private and public 
sector constituents to make health protection a practical reality.
    Matters to be Considered: The agenda will include discussions 
regarding CDC's current and future work in the following topic areas: 
(1) Data modernization; (2) laboratory quality; and (3) health equity. 
The Advisory Committee to the Director (ACD) will consider the 
formation of working groups for each of the first two topics and hear a 
report from the existing health equity working group on the third 
topic. Agenda items are subject to change as priorities dictate.

Public Participation

    Interested persons or organizations are invited to participate by 
submitting written views, recommendations, and data. Please note that 
comments received, including attachments and other supporting 
materials, are part of the public record and are subject to public 
disclosure. Comments will be

[[Page 19939]]

posted on https://www.regulations.gov. Therefore, do not include any 
information in your comment or supporting materials that you consider 
confidential or inappropriate for public disclosure. If you include 
your name, contact information, or other information that identifies 
you in the body of your comments, that information will be on public 
display. CDC will review all submissions and may choose to redact, or 
withhold, submissions containing private or proprietary information 
such as Social Security numbers, medical information, inappropriate 
language, or duplicate/near duplicate examples of a mass-mail campaign. 
CDC will carefully consider all comments submitted into the docket.
    Written Public Comment: The docket will be opened to receive 
written comments on April 6, 2022 through April 28, 2022.
    Oral Public Comment: This meeting will include time for members of 
the public to make an oral comment. Oral public comment will occur 
before any scheduled votes. Priority will be given to individuals who 
submit a request to make an oral public comment before the meeting 
according to the procedures below.
    Procedure for Oral Public Comment: All persons interested in making 
an oral public comment at the May 3, 2022, ACD meeting must submit a 
request by visiting https://www.cdc.gov/about/advisory-committee-director/ no later than 11:59 p.m., EDT, April 22, 2022, according to 
the instructions provided.
    If the number of persons requesting to speak is greater than can be 
reasonably accommodated during the scheduled time, CDC will conduct a 
lottery to determine the speakers for the scheduled public comment 
session. CDC staff will notify individuals regarding their request to 
speak by email by April 26, 2022. To accommodate the significant 
interest in participation in the oral public comment session of ACD 
meetings, each speaker will be limited to 2 minutes, and each speaker 
may only speak once per meeting.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-07247 Filed 4-5-22; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>